Arizona health officials are concerned a measles outbreak in the Tucson area could spread across the state.
There have been nine reported cases of measles in the Tucson area, the Pima County Health Department said Monday in a news release. "Measles is extremely contagious, so the best way to prevent the disease is to get vaccinated," chief medical officer Dr. Michelle McDonald said in a statement.
The health department recommends an accelerated schedule for vaccinating children, with one dose between the ages of 6 and 12 months of age and two more doses starting on the child's first birthday.
Dr. Karen Lewis, a medical director with the Arizona Department of Health Services, said health officials are concerned that some parents aren't vaccinating their children because of concerns about links to autism.
"People have started to forget how bad of a disease it is and have started listening to people saying vaccines aren't good," Lewis told The Arizona Republic.
Copyright 2008 by United Press International
Related stories:
Research suggests America may over-vaccinate
A new study published in the
New England Journal of Medicine this week by Oregon Health & Science University researchers suggests that timelines for vaccinating and revaccinating Americans against disease should possibly be reevaluated and adjusted. The study shows that in many cases, the established duration of protective immunity for many vaccines is greatly underestimated. This means that people are getting booster shots when their immunity levels most likely do not require it. The results are published in the November 8 edition of the journal.
Measles vaccinations need to be repeated to protect HIV-infected children
HIV-infected children may require repeat measles vaccination for protection, according to new research from the Johns Hopkins Bloomberg School of Public Health and other institutions. The researchers found that only half of the HIV-infected children who survived without antiretroviral therapy maintained protective antibody levels 27 months after receiving measles vaccine.
'Flu Chip' May Help Combat Future Epidemics, Pandemics
A novel "Flu Chip" developed at the University of Colorado at Boulder that can determine the genetic signatures of specific influenza strains from patient samples within hours may help world health officials combat coming epidemics and pandemics.
Tech firms fare better than most in jobs slump
(AP) -- Technology appears to be one of the least hard-hit sectors in an economy beset by unemployment at a five-year high. The Labor Department reported Friday that companies slashed their payrolls by 84,000 jobs last month, sending the country's unemployment rate to 6.1 percent from 5.7 percent in July.
More off-premise alcohol outlets can lead to more injuries among neighborhood children
Childhood injuries constitute a serious issue in the United States. In 2001, there were 12,249 deaths among children ages one to 14: injuries were the leading cause, accounting for 33.2 percent of all deaths for children ages one to four, and 39.4 percent of all deaths for children ages five to 14. A new study has found that numerous off-premise alcohol outlets in neighborhoods can reduce overall guardianship of children's activities, leading to increased injuries.
Future of biology rests in harnessing data avalanche
(PhysOrg.com) -- Like most sciences, biology is inundated with data. However, a group of researchers warns in a
Nature feature that the avalanche of biological information is at the point where the discipline may be unable to reach its full potential without improvements for curating data into on-line databases. The commentary appears in the September 4, issue of the journal and outlines specific remedies to harness the information overload.
Study shows no connection between measles, mumps, rubella (MMR) vaccine and autism
In a case-control study, the presence of measles virus RNA was no more likely in children with autism and GI disturbances than in children with only GI disturbances. Furthermore, GI symptom and autism onset were unrelated to MMR vaccine timing.
International team reveals first prognosticator of survival in aggressive cancer
The tumor suppressor gene pRb2/p130 may provide the first independent prognostic biomarker in cases of soft tissue sarcoma (STS), according to an international collaboration of researchers, including scientists at the Sbarro Institute for Cancer Research and Molecular Medicine at the College of Science and Technology at Temple University in Philadelphia, PA, the Department of Human Pathology and Oncology, University of Siena and the Center of Oncological Research of Mercogliano (CROM) in Avellino, Italy.